Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/TG Therapeutics, Inc./ 10-Q

Quarterly Report · 10-Q

TG Therapeutics, Inc.

TGTXNASDAQEQUITYCurrent

Quarterly Report

Filed May 6, 2026Accepted May 6, 2026, 5:00 PM EDTCIK 1001316Accession 0001437749-26-015246
View company →Permanent SEC source ↗
Share

Company context

Current securities

TGTXNASDAQ · EQUITY · Current

Recent company filings

  1. 144 filingSep 10, 2026
  2. 10-Q filingAug 5, 2026
  3. Results of Operations and Financial ConditionAug 3, 2026
  4. 4 filingJun 15, 2026
  5. 4 filingJun 15, 2026

As-filed source

Primary evidence
As filedOpen full document ↗